Xiaosu Yang
Overview
Explore the profile of Xiaosu Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu H, Zhao H, Liu K, Jia Z, Dong M, Cheng Y, et al.
Obes Facts
. 2024 Apr;
17(3):286-295.
PMID: 38569473
Introduction: Medication-overuse headache (MOH) is a secondary chronic headache disorder that occurs in individuals with a pre-existing primary headache disorder, particularly migraine disorder. Obesity is often combined with chronic daily...
2.
Liu H, Dong M, Liu K, Jia Z, Gui W, Cheng Y, et al.
J Headache Pain
. 2023 Aug;
24(1):119.
PMID: 37653478
Background: Headache disorders are widely prevalent and pose a considerable economic burden on individuals and society. Globally, misdiagnosis and inadequate treatment of primary headache disorders remain significant challenges, impeding the...
3.
Zhou J, Zhong L, Chowdhury D, Skorobogatykh K, Luo G, Yang X, et al.
J Headache Pain
. 2023 Aug;
24(1):103.
PMID: 37542222
Background: The phase 3 randomized PERSIST study demonstrated the efficacy and tolerability of galcanezumab, a humanized anti-calcitonin gene-related peptide (CGRP) monoclonal antibody for prevention of episodic migraines. We present findings...
4.
Dong Z, Liu K, Liu H, Jia Z, Gui W, Dong M, et al.
Headache
. 2023 Jan;
63(1):62-70.
PMID: 36651491
Objective: The aims were to explore the prevalence and clinical features of fibromyalgia in Chinese hospital patients with primary headache. Background: Studies done in non-Chinese populations suggest that around one-third...
5.
Yang X, Tian J, Wan Y, Chen M, Chen L, Chen J
Med Phys
. 2023 Jan;
50(7):4269-4281.
PMID: 36636813
Background: Semi-supervised learning is becoming an effective solution for medical image segmentation because of the lack of a large amount of labeled data. Purpose: Consistency-based strategy is widely used in...
6.
Zhou J, Luo G, Xu Y, Yang X, Pan X, Dong Z, et al.
Adv Ther
. 2022 Sep;
39(11):5229-5243.
PMID: 36114949
Introduction: Lasmiditan is the first 5-HT receptor agonist with potential to address the huge unmet medical needs for the treatment of migraine in China. The CENTURION study was the first...
7.
Yu T, He L, Yang X, Zhou J, Luo G, Wang H, et al.
Neurol Ther
. 2022 Jun;
11(3):1269-1283.
PMID: 35713760
Introduction: Over the last two decades, there has been no novel acute treatment for migraine to address the large unmet medical need in Chinese patients. Lasmiditan, a novel selective serotonin ...
8.
Luo Y, Tang W, Zeng Q, Duan W, Li S, Yang X, et al.
Front Cardiovasc Med
. 2021 Sep;
8:714460.
PMID: 34485412
The neuromuscular adverse events of immune checkpoint inhibitor (ICI) treatment include myositis, polymyalgia rheumatica, myocarditis, and myasthenia syndrome. We report a 47-year old female presenting with external ophthalmoplegia, generalized muscle...
9.
Fu Y, Zhou C, Song R, Peng J, Yang X, Xiao B, et al.
Neurol Sci
. 2020 Apr;
41(8):2267-2270.
PMID: 32342326
EPM2A has been certified as a causative gene in patients with Lafora disease (LD), which is a rare autosomal recessive and severe form of progressive myoclonus epilepsy. LD classically starts...
10.
Yu S, Ran Y, Wan Q, Yang X, Chen H, Wang H, et al.
J Altern Complement Med
. 2019 Sep;
25(12):1215-1224.
PMID: 31553228
Toutongning (TTN) capsule, a Chinese patent medicine, is used as a prophylactic treatment for migraine. The present study was conducted as a postmarketing evaluation of the efficacy and safety of...